Copyright Reports & Markets. All rights reserved.

Global Pressurized Metered Dose Inhaler Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pressurized Metered Dose Inhaler Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Manual Pressurized Metered Dose Inhaler
    • 1.3.3 Smart Pressurized Metered Dose Inhaler
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pressurized Metered Dose Inhaler Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Asthma
    • 1.4.3 COPD
    • 1.4.4 Others
  • 1.5 Global Pressurized Metered Dose Inhaler Market Size & Forecast
    • 1.5.1 Global Pressurized Metered Dose Inhaler Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Pressurized Metered Dose Inhaler Sales Quantity (2019-2030)
    • 1.5.3 Global Pressurized Metered Dose Inhaler Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 GlaxoSmithKline
    • 2.1.1 GlaxoSmithKline Details
    • 2.1.2 GlaxoSmithKline Major Business
    • 2.1.3 GlaxoSmithKline Pressurized Metered Dose Inhaler Product and Services
    • 2.1.4 GlaxoSmithKline Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 GlaxoSmithKline Recent Developments/Updates
  • 2.2 Chiesi Farmaceutici S.p.A
    • 2.2.1 Chiesi Farmaceutici S.p.A Details
    • 2.2.2 Chiesi Farmaceutici S.p.A Major Business
    • 2.2.3 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Product and Services
    • 2.2.4 Chiesi Farmaceutici S.p.A Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Chiesi Farmaceutici S.p.A Recent Developments/Updates
  • 2.3 AstraZeneca
    • 2.3.1 AstraZeneca Details
    • 2.3.2 AstraZeneca Major Business
    • 2.3.3 AstraZeneca Pressurized Metered Dose Inhaler Product and Services
    • 2.3.4 AstraZeneca Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AstraZeneca Recent Developments/Updates
  • 2.4 Teva
    • 2.4.1 Teva Details
    • 2.4.2 Teva Major Business
    • 2.4.3 Teva Pressurized Metered Dose Inhaler Product and Services
    • 2.4.4 Teva Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Teva Recent Developments/Updates
  • 2.5 Merck & Co. Inc
    • 2.5.1 Merck & Co. Inc Details
    • 2.5.2 Merck & Co. Inc Major Business
    • 2.5.3 Merck & Co. Inc Pressurized Metered Dose Inhaler Product and Services
    • 2.5.4 Merck & Co. Inc Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Merck & Co. Inc Recent Developments/Updates
  • 2.6 Boehringer Ingelheim
    • 2.6.1 Boehringer Ingelheim Details
    • 2.6.2 Boehringer Ingelheim Major Business
    • 2.6.3 Boehringer Ingelheim Pressurized Metered Dose Inhaler Product and Services
    • 2.6.4 Boehringer Ingelheim Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.7 Mylan
    • 2.7.1 Mylan Details
    • 2.7.2 Mylan Major Business
    • 2.7.3 Mylan Pressurized Metered Dose Inhaler Product and Services
    • 2.7.4 Mylan Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Mylan Recent Developments/Updates
  • 2.8 Arkon
    • 2.8.1 Arkon Details
    • 2.8.2 Arkon Major Business
    • 2.8.3 Arkon Pressurized Metered Dose Inhaler Product and Services
    • 2.8.4 Arkon Pressurized Metered Dose Inhaler Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Arkon Recent Developments/Updates

3 Competitive Environment: Pressurized Metered Dose Inhaler by Manufacturer

  • 3.1 Global Pressurized Metered Dose Inhaler Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Pressurized Metered Dose Inhaler Revenue by Manufacturer (2019-2024)
  • 3.3 Global Pressurized Metered Dose Inhaler Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Pressurized Metered Dose Inhaler by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Pressurized Metered Dose Inhaler Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Pressurized Metered Dose Inhaler Manufacturer Market Share in 2023
  • 3.5 Pressurized Metered Dose Inhaler Market: Overall Company Footprint Analysis
    • 3.5.1 Pressurized Metered Dose Inhaler Market: Region Footprint
    • 3.5.2 Pressurized Metered Dose Inhaler Market: Company Product Type Footprint
    • 3.5.3 Pressurized Metered Dose Inhaler Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pressurized Metered Dose Inhaler Market Size by Region
    • 4.1.1 Global Pressurized Metered Dose Inhaler Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Pressurized Metered Dose Inhaler Consumption Value by Region (2019-2030)
    • 4.1.3 Global Pressurized Metered Dose Inhaler Average Price by Region (2019-2030)
  • 4.2 North America Pressurized Metered Dose Inhaler Consumption Value (2019-2030)
  • 4.3 Europe Pressurized Metered Dose Inhaler Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Pressurized Metered Dose Inhaler Consumption Value (2019-2030)
  • 4.5 South America Pressurized Metered Dose Inhaler Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Pressurized Metered Dose Inhaler Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Pressurized Metered Dose Inhaler Sales Quantity by Type (2019-2030)
  • 5.2 Global Pressurized Metered Dose Inhaler Consumption Value by Type (2019-2030)
  • 5.3 Global Pressurized Metered Dose Inhaler Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Pressurized Metered Dose Inhaler Sales Quantity by Application (2019-2030)
  • 6.2 Global Pressurized Metered Dose Inhaler Consumption Value by Application (2019-2030)
  • 6.3 Global Pressurized Metered Dose Inhaler Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Pressurized Metered Dose Inhaler Sales Quantity by Type (2019-2030)
  • 7.2 North America Pressurized Metered Dose Inhaler Sales Quantity by Application (2019-2030)
  • 7.3 North America Pressurized Metered Dose Inhaler Market Size by Country
    • 7.3.1 North America Pressurized Metered Dose Inhaler Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Pressurized Metered Dose Inhaler Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Pressurized Metered Dose Inhaler Sales Quantity by Type (2019-2030)
  • 8.2 Europe Pressurized Metered Dose Inhaler Sales Quantity by Application (2019-2030)
  • 8.3 Europe Pressurized Metered Dose Inhaler Market Size by Country
    • 8.3.1 Europe Pressurized Metered Dose Inhaler Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Pressurized Metered Dose Inhaler Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pressurized Metered Dose Inhaler Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Pressurized Metered Dose Inhaler Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Pressurized Metered Dose Inhaler Market Size by Region
    • 9.3.1 Asia-Pacific Pressurized Metered Dose Inhaler Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Pressurized Metered Dose Inhaler Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Pressurized Metered Dose Inhaler Sales Quantity by Type (2019-2030)
  • 10.2 South America Pressurized Metered Dose Inhaler Sales Quantity by Application (2019-2030)
  • 10.3 South America Pressurized Metered Dose Inhaler Market Size by Country
    • 10.3.1 South America Pressurized Metered Dose Inhaler Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Pressurized Metered Dose Inhaler Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pressurized Metered Dose Inhaler Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Pressurized Metered Dose Inhaler Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Pressurized Metered Dose Inhaler Market Size by Country
    • 11.3.1 Middle East & Africa Pressurized Metered Dose Inhaler Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Pressurized Metered Dose Inhaler Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Pressurized Metered Dose Inhaler Market Drivers
  • 12.2 Pressurized Metered Dose Inhaler Market Restraints
  • 12.3 Pressurized Metered Dose Inhaler Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pressurized Metered Dose Inhaler and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pressurized Metered Dose Inhaler
  • 13.3 Pressurized Metered Dose Inhaler Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pressurized Metered Dose Inhaler Typical Distributors
  • 14.3 Pressurized Metered Dose Inhaler Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    A metered-dose inhaler (MDI) is a device that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation. It is the most commonly used delivery system for treating asthma, chronic obstructive pulmonary disease (COPD) and other respiratory diseases. The medication in a metered dose inhaler is most commonly a bronchodilator, corticosteroid or a combination of both for the treatment of asthma and COPD. Other medications less commonly used but also administered by MDI are mast cell stabilizers, such as cromoglicate or nedocromil.
    According to our (Global Info Research) latest study, the global Pressurized Metered Dose Inhaler market size was valued at US$ 6441 million in 2023 and is forecast to a readjusted size of USD 8128 million by 2030 with a CAGR of 3.4% during review period.
    The classification of Pressurized Metered Dose Inhaler includes manual type and smart type. The proportion of manual type in 2019 is about 99%. But the smart metered-dose inhaler will have a much higher growth rate in the future.
    Pressurized Metered Dose Inhaler is widely used for Asthma, COPD and Others. The most proportion of Pressurized Metered Dose Inhaler used for Asthma, and the proportion in 2019 is about 48.94%.
    North America is the largest market, with a market share nearly 44.49% in 2019. Following North America, Europe is the second largest sales place with the sales market share of 26.40%.
    Market competition is intense. GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
    This report is a detailed and comprehensive analysis for global Pressurized Metered Dose Inhaler market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Pressurized Metered Dose Inhaler market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Pressurized Metered Dose Inhaler market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Pressurized Metered Dose Inhaler market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
    Global Pressurized Metered Dose Inhaler market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pressurized Metered Dose Inhaler
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pressurized Metered Dose Inhaler market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Chiesi Farmaceutici S.p.A, AstraZeneca, Teva, Merck & Co. Inc, Boehringer Ingelheim, Mylan, Arkon, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Pressurized Metered Dose Inhaler market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Manual Pressurized Metered Dose Inhaler
    Smart Pressurized Metered Dose Inhaler
    Market segment by Application
    Asthma
    COPD
    Others
    Major players covered
    GlaxoSmithKline
    Chiesi Farmaceutici S.p.A
    AstraZeneca
    Teva
    Merck & Co. Inc
    Boehringer Ingelheim
    Mylan
    Arkon
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pressurized Metered Dose Inhaler product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pressurized Metered Dose Inhaler, with price, sales quantity, revenue, and global market share of Pressurized Metered Dose Inhaler from 2019 to 2024.
    Chapter 3, the Pressurized Metered Dose Inhaler competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pressurized Metered Dose Inhaler breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Pressurized Metered Dose Inhaler market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pressurized Metered Dose Inhaler.
    Chapter 14 and 15, to describe Pressurized Metered Dose Inhaler sales channel, distributors, customers, research findings and conclusion.

    Buy now